Literature DB >> 19780184

Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis.

Patrick Sparrow1, Afsaneh Amirabadi, Marshall S Sussman, Narinder Paul, Naeem Merchant.   

Abstract

PURPOSE: To evaluate cardiac MRI (CMR) in the diagnosis of cardiac amyloidosis by comparing the T2 relaxation times of left ventricular myocardium in a pilot patient group to a normal range established in healthy controls.
MATERIALS AND METHODS: Forty-nine patients with suspected amyloidosis-related cardiomyopathy underwent comprehensive CMR examination, which included assessment of myocardial T2 relaxation times, ventricular function, resting myocardial perfusion, and late gadolinium enhancement (LGE) imaging. T2-weighted basal, mid, and apical left ventricular slices were acquired in each patient using a multislice T2 magnetization preparation spiral sequence. Slice averaged T2 relaxation times were subsequently calculated offline and compared to the previously established normal range.
RESULTS: Twelve of the 49 patients were confirmed to have cardiac amyloidosis by biopsy. There was no difference in mean T2 relaxation times between the amyloid cases and normal controls (51.3 +/- 8.1 vs. 52.1 +/- 3.1 msec, P = 0.63). Eleven of the 12 amyloid patients had abnormal findings by CMR, eight having LGE involving either ventricles or atria and four demonstrating resting subendocardial perfusion defects.
CONCLUSION: CMR is a potentially valuable tool in the diagnosis of cardiac amyloidosis. However, calculation of myocardial T2 relaxation times does not appear useful in distinguishing areas of amyloid deposition from normal myocardium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19780184     DOI: 10.1002/jmri.21918

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  15 in total

Review 1.  MR, CT, and PET imaging in pericardial disease.

Authors:  Peter Alter; Jens H Figiel; Thomas P Rupp; Georg F Bachmann; Bernhard Maisch; Marga B Rominger
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

2.  Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.

Authors:  Ralf Wassmuth; Hassan Abdel-Aty; Steffen Bohl; Jeanette Schulz-Menger
Journal:  Eur Radiol       Date:  2011-03-29       Impact factor: 5.315

3.  T2 Relaxation Times at Cardiac MRI in Healthy Adults: A Systematic Review and Meta-Analysis.

Authors:  Christopher A Hanson; Akshay Kamath; Matthew Gottbrecht; Sami Ibrahim; Michael Salerno
Journal:  Radiology       Date:  2020-08-25       Impact factor: 11.105

4.  Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy.

Authors:  Tatsuya Nishii; Atsushi K Kono; Mayumi Shigeru; Sachiko Takamine; Sei Fujiwara; Katsusuke Kyotani; Nobukazu Aoyama; Kazuro Sugimura
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-09       Impact factor: 2.357

Review 5.  Imaging of early modification in cardiomyopathy: the doxorubicin-induced model.

Authors:  Mohamed Aissiou; Delphine Périé; Farida Cheriet; Nagib S Dahdah; Caroline Laverdière; Daniel Curnier
Journal:  Int J Cardiovasc Imaging       Date:  2013-06-07       Impact factor: 2.357

6.  T2 quantification for improved detection of myocardial edema.

Authors:  Shivraman Giri; Yiu-Cho Chung; Ali Merchant; Georgeta Mihai; Sanjay Rajagopalan; Subha V Raman; Orlando P Simonetti
Journal:  J Cardiovasc Magn Reson       Date:  2009-12-30       Impact factor: 5.364

Review 7.  Pathophysiology and treatment of systemic amyloidosis.

Authors:  Julian D Gillmore; Philip N Hawkins
Journal:  Nat Rev Nephrol       Date:  2013-08-27       Impact factor: 28.314

8.  Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis.

Authors:  Ali M Agha; Nicolas Palaskas; Amit R Patel; Jeanne DeCara; Purvi Parwani; Cezar Iliescu; Jean B Durand; Peter Kim; Saamir Hassan; Gregory Gladish; Hans C Lee; Gregory P Kaufman; Juan C Lopez-Mattei
Journal:  Front Cardiovasc Med       Date:  2021-06-29

9.  Updates in cardiac amyloidosis: a review.

Authors:  Sanjay M Banypersad; James C Moon; Carol Whelan; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

10.  Cardiac magnetic resonance imaging of systemic amyloidosis patients with normal left ventricular ejection fraction: An initial study.

Authors:  Rui Xia; Fabao Gao; Jiayu Sun; Chunchao Xia; Zhangxue Hu; Yingkun Guo
Journal:  Pak J Med Sci       Date:  2013-11       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.